These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. p53 is phosphorylated by CDK7-cyclin H in a p36MAT1-dependent manner. Ko LJ; Shieh SY; Chen X; Jayaraman L; Tamai K; Taya Y; Prives C; Pan ZQ Mol Cell Biol; 1997 Dec; 17(12):7220-9. PubMed ID: 9372954 [TBL] [Abstract][Full Text] [Related]
31. Disruption of the cyclin D/cyclin-dependent kinase/INK4/retinoblastoma protein regulatory pathway in human neuroblastoma. Easton J; Wei T; Lahti JM; Kidd VJ Cancer Res; 1998 Jun; 58(12):2624-32. PubMed ID: 9635589 [TBL] [Abstract][Full Text] [Related]
32. A cyclin-dependent kinase-activating kinase (CAK) in budding yeast unrelated to vertebrate CAK. Espinoza FH; Farrell A; Erdjument-Bromage H; Tempst P; Morgan DO Science; 1996 Sep; 273(5282):1714-7. PubMed ID: 8781234 [TBL] [Abstract][Full Text] [Related]
33. Dual phosphorylation of the T-loop in cdk7: its role in controlling cyclin H binding and CAK activity. Martinez AM; Afshar M; Martin F; Cavadore JC; Labbé JC; Dorée M EMBO J; 1997 Jan; 16(2):343-54. PubMed ID: 9029154 [TBL] [Abstract][Full Text] [Related]
34. KSHV viral cyclin interferes with T-cell development and induces lymphoma through Cdk6 and Notch activation in vivo. Pekkonen P; Järviluoma A; Zinovkina N; Cvrljevic A; Prakash S; Westermarck J; Evan GI; Cesarman E; Verschuren EW; Ojala PM Cell Cycle; 2014; 13(23):3670-84. PubMed ID: 25483078 [TBL] [Abstract][Full Text] [Related]
35. Effects of phosphorylation by CAK on cyclin binding by CDC2 and CDK2. Desai D; Wessling HC; Fisher RP; Morgan DO Mol Cell Biol; 1995 Jan; 15(1):345-50. PubMed ID: 7799941 [TBL] [Abstract][Full Text] [Related]
36. B cell antigen receptor-mediated activation of cyclin-dependent retinoblastoma protein kinases and inhibition by co-cross-linking with Fc gamma receptors. Tanguay D; Pavlovic S; Piatelli MJ; Bartek J; Chiles TC J Immunol; 1999 Sep; 163(6):3160-8. PubMed ID: 10477583 [TBL] [Abstract][Full Text] [Related]
37. Novel expression of cyclin-dependent kinase inhibitors in human B-cell precursors. Fink JR; LeBien TW Exp Hematol; 2001 Apr; 29(4):490-8. PubMed ID: 11301189 [TBL] [Abstract][Full Text] [Related]
38. Interferon-induces expression of cyclin-dependent kinase-inhibitors p21WAF1 and p27Kip1 that prevent activation of cyclin-dependent kinase by CDK-activating kinase (CAK). Mandal M; Bandyopadhyay D; Goepfert TM; Kumar R Oncogene; 1998 Jan; 16(2):217-25. PubMed ID: 9464540 [TBL] [Abstract][Full Text] [Related]
39. Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a. Russo AA; Tong L; Lee JO; Jeffrey PD; Pavletich NP Nature; 1998 Sep; 395(6699):237-43. PubMed ID: 9751050 [TBL] [Abstract][Full Text] [Related]
40. Analysis of CAK activities from human cells. Kaldis P; Solomon MJ Eur J Biochem; 2000 Jul; 267(13):4213-21. PubMed ID: 10866826 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]